Ipek Yonal-Hindilerden

9PUBLICATIONS
66CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Respiratory diseasesTransplantation immunologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 30, 2026
Analysis of CALR-mutated essential thrombocythemia as a distinct disease entity compared with JAK2 V617F-mutated and triple-negative patients.

|Mar 07, 2026
Length of SARS-CoV-2 shedding in HCT recipients: an Infectious Disease Working Party of EBMT study.

Malgorzata Mikulska, Gloria Tridello, Per Ljungman

|Oct 15, 2025
Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT.

Patryk Sobieralski, Tomasz Czerw, Luuk Gras

|Aug 06, 2025
The role of CD40L-expressing CXCR5+CD8+ follicular cytotoxic T cells in chronic lymphocytic leukemia.

Fatih Akboga, Fehmi Hindilerden, Ipek Yonal Hindilerden

|Apr 13, 2025
Anti-T lymphocyte globulin plus posttransplant cyclophosphamide 25 mg/kg versus posttransplant cyclophosphamide 50 mg/kg in patients with acute leukemias.

Abdullah Karakus, Tayfur Toptas, Mehmet Sinan Dal

|Aug 08, 2024
Secondary Solid Cancers in Patients with Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Multicenter Study

Fehmi Hindilerden, Özge Nuran Akay, Elif Aksoy

Pageof 2

Frequent Collaborators

6 joint publications

Fehmi Hindilerden

4 joint publications

Aynur Daglar-Aday

4 joint publications

Meliha Nalçacı

3 joint publications

Emine Gulturk